All In MedTech

Device Trial Radar · NCT03048955

Assessing Superion Clinical Endpoints vs. Decompression

A 2 and 5 Year Comparative Evaluation of Clinical Outcomes in the Treatment of Moderate Lumbar Spinal Stenosis With the Superion® Indirect Decompression System (IDS) vs. Direct Decompression Surgery for FDA Actual Conditions of Use Study

Last checked: Nov 19, 2026Latest source record: Jun 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Feb 8, 2017

Primary completion

Jul 31, 2022

Study completion Jul 31, 2025

Sponsor

Lead sponsor
VertiFlex, IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Feb 9, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

PURPOSE: The primary purpose of this study is to demonstrate that the Composite Clinical Success of the study group receiving the Superion® IDS is not inferior to the success rate observed in the study group treated by direct decompression at 60 months follow-up. Secondarily, the trial is intended to establish that Composite Clinical Success of the study group receiving the Superion® IDS at 24 months is not inferior to the success rate observed at 24 months in patients treated with the Superion® IDS in the original IDE trial. Thirdly, the trial is intended to establish that Composite Clinical Success of the population receiving the Superion® IDS in this trial at 24 months is not inferior to the success rate observed at 24 months in patients treated with direct decompression.

Conditions

  • Spinal Stenosis, Lumbar Region With Neurogenic Claudication

Interventions

  • Superion® IDSDevice

    Device is a non-fusion, spinal column load-sharing device used to stabilize the spine at the implanted leve

  • Direct decompression SurgeryProcedure

    A surgical procedure - the control

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite Endpoint (Primary)Time frame: 60 Months
  2. Zurich Claudication Questionnaire (ZCQ)Time frame: 60 Months
  3. No re-operations, revisions, removals, or supplemental fixation at the index level(s)Time frame: 60 Months

1 more outcomes with a free account

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Alabama Clinical Therapeutics, LLC

    Birmingham, Alabama

  • Coastal Pain Spinal Diagnostics

    Carlsbad, California

  • Lake Nona Medical Arts

    Celebration, Florida

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.